+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

HIV Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

HIV Drugs Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
From
Allergy Treatment - Global Strategic Business Report - Product Thumbnail Image

Allergy Treatment - Global Strategic Business Report

  • Report
  • April 2025
  • 148 Pages
  • Global
From
From
From
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Arthritis Monoclonal Antibodies Market Report 2025 - Product Thumbnail Image

Arthritis Monoclonal Antibodies Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Conjugated Monoclonal Antibodies Market Report 2025 - Product Thumbnail Image

Conjugated Monoclonal Antibodies Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Ulcerative Colitis - Pipeline Insight, 2024 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
From
From
Cell Therapy Market Report 2025 - Product Thumbnail Image

Cell Therapy Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Loading Indicator